Stevanato Group S.p.A. (STVN)
NYSE: STVN · IEX Real-Time Price · USD
26.45
-0.36 (-1.34%)
May 3, 2024, 4:00 PM EDT - Market closed
Stevanato Group Revenue
In the year 2023, Stevanato Group had annual revenue of $1.21B with 15.24% growth. Revenue in the quarter ending December 31, 2023 was $356.27M with 14.65% year-over-year growth.
Revenue (ttm)
$1.21B
Revenue Growth
+15.24%
P/S Ratio
6.66
Revenue / Employee
$214,048
Employees
5,634
Market Cap
8.04B USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.21B | 159.48M | 15.24% |
Dec 31, 2022 | 1.05B | 87.47M | 9.12% |
Dec 31, 2021 | 959.00M | 151.64M | 18.78% |
Dec 31, 2020 | 807.36M | 204.51M | 33.92% |
Dec 31, 2019 | 602.85M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Henry Schein | 12.34B |
Encompass Health | 4.80B |
Bio-Rad Laboratories | 2.67B |
Chemed | 2.29B |
Qiagen | 1.94B |
Penumbra | 1.06B |
Repligen | 607.45M |
Legend Biotech | 285.14M |
STVN News
- 3 days ago - Stevanato Group to Present at the Bank of America Securities Healthcare Conference - Business Wire
- 9 days ago - Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024 - Business Wire
- 5 weeks ago - Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary Shares - Business Wire
- 6 weeks ago - Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares - Business Wire
- 6 weeks ago - Stevanato Group Announces Public Offering of Ordinary Shares - Business Wire
- 7 weeks ago - Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum - Business Wire
- 2 months ago - Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023 - Business Wire
- 2 months ago - Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024 - Business Wire